Patent · US Expired

Urokinase inhibitors

US6624169B1 · kind B1 · utility

17Cited by
0References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 3, 2001
Grant dateSep 23, 2003
Priority date
Expiry dateApr 3, 2021

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D295/205
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to the use of derivatives of 3-amidinophenylalanine as urokinase inhibitors for treating malignant tumors and the formation of metastases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.